
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Adding Antioxidants Into Human Sequential Culture Media System
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Blastocyst.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 21, 2016
Lead Product(s) : Undisclosed
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Recipient : Fertilitetscentrum AB
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Acetyl-L-Carnitine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Blastocyst.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
November 23, 2016
Lead Product(s) : Acetyl-L-Carnitine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Recipient : Fertilitetscentrum AB
Deal Size : Inapplicable
Deal Type : Inapplicable
